We are offering the third mRNA COVID-19 vaccine dose for immunocompromised persons. The Centers for Disease Control and Prevention (CDC) recommends that immunocompromised persons receive a third dose of the mRNA COVID-19 vaccine (Pfizer BioNTech or Moderna) 28 days after the second dose. (If you received the Johnson & Johnson Janssen vaccine, there is no current recommendation to receive a second dose.) Persons who qualify for the third dose include those who have: Been receiving cancer treatment for tumors or cancers of the blood Received an organ transplant and are taking medicine to suppress the immune system Received a stem
Read More